Staging of cutaneous melanoma
Identifieur interne : 006450 ( Main/Curation ); précédent : 006449; suivant : 006451Staging of cutaneous melanoma
Auteurs : P. Mohr [Allemagne] ; A. M. M. Eggermont [Pays-Bas] ; A. Hauschild [Allemagne] ; A. Buzaid [Brésil]Source :
- Annals of Oncology [ 0923-7534 ] ; 2009.
Abstract
The American Joint Committee on Cancer (AJCC) staging of cutaneous melanoma is a continuously evolving system. The identification of increasingly more accurate prognostic factors has led to major changes in melanoma staging over the years, and the current system described in this review will likely be modified in the near future. Likewise, application of new imaging techniques has also changed the staging work-up of patients with cutaneous melanoma. Chest and abdominal computed tomography (CT) scanning is most commonly used for evaluation of potential metastatic sites in the lungs, lymph nodes and liver, and is indicated in patients with new symptoms, anaemia, elevated lactate dehydrogenase or a chest X-ray abnormality. CT scans should be restricted to patients with high-risk melanoma (stage IIC, IIIB, IIIC and stage IIIA with a macroscopic sentinel lymph node). Magnetic resonance imaging (MRI) of the brain is a mandatory test in patients with stage IV, optional in stage III and not used in patients with stage I and II disease. Positron emission tomography (PET)/CT is more accurate than CT or MRI alone in the diagnosis of metastases and should complement conventional CT/MRI imaging in the staging work-up of patients who have solitary or oligometastatic disease where surgical resection is most relevant.
Url:
- https://api.istex.fr/document/589851F42F3B662B4BF40B6CE86D13FE01352A8D/fulltext/pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712594
DOI: 10.1093/annonc/mdp256
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002893
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :002893
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000B90
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003B09
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :003B08
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003583
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003517
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :003517
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003517
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006528
Links to Exploration step
ISTEX:589851F42F3B662B4BF40B6CE86D13FE01352A8DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Staging of cutaneous melanoma</title>
<author><name sortKey="Mohr, P" sort="Mohr, P" uniqKey="Mohr P" first="P." last="Mohr">P. Mohr</name>
</author>
<author><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A. M. M." last="Eggermont">A. M. M. Eggermont</name>
</author>
<author><name sortKey="Hauschild, A" sort="Hauschild, A" uniqKey="Hauschild A" first="A." last="Hauschild">A. Hauschild</name>
</author>
<author><name sortKey="Buzaid, A" sort="Buzaid, A" uniqKey="Buzaid A" first="A." last="Buzaid">A. Buzaid</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:589851F42F3B662B4BF40B6CE86D13FE01352A8D</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1093/annonc/mdp256</idno>
<idno type="url">https://api.istex.fr/document/589851F42F3B662B4BF40B6CE86D13FE01352A8D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002893</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002893</idno>
<idno type="wicri:Area/Istex/Curation">002893</idno>
<idno type="wicri:Area/Istex/Checkpoint">000B90</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000B90</idno>
<idno type="wicri:doubleKey">0923-7534:2009:Mohr P:staging:of:cutaneous</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712594</idno>
<idno type="RBID">PMC:2712594</idno>
<idno type="wicri:Area/Pmc/Corpus">003B09</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003B09</idno>
<idno type="wicri:Area/Pmc/Curation">003B08</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003B08</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003583</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003583</idno>
<idno type="wicri:Area/Ncbi/Merge">003517</idno>
<idno type="wicri:Area/Ncbi/Curation">003517</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003517</idno>
<idno type="wicri:doubleKey">0923-7534:2009:Mohr P:staging:of:cutaneous</idno>
<idno type="wicri:Area/Main/Merge">006528</idno>
<idno type="wicri:Area/Main/Curation">006450</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Staging of cutaneous melanoma</title>
<author><name sortKey="Mohr, P" sort="Mohr, P" uniqKey="Mohr P" first="P." last="Mohr">P. Mohr</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Elbekliniken, Buxtehude</wicri:regionArea>
<wicri:noRegion>Buxtehude</wicri:noRegion>
<wicri:noRegion>Buxtehude</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A. M. M." last="Eggermont">A. M. M. Eggermont</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Surgical Oncology, Erasmus University Medical CenterDaniel den Hoed Cancer Center, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hauschild, A" sort="Hauschild, A" uniqKey="Hauschild A" first="A." last="Hauschild">A. Hauschild</name>
<affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Dermatology, University of Kiel, Kiel</wicri:regionArea>
<placeName><region type="land" nuts="2">Schleswig-Holstein</region>
<settlement type="city">Kiel</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Buzaid, A" sort="Buzaid, A" uniqKey="Buzaid A" first="A." last="Buzaid">A. Buzaid</name>
<affiliation wicri:level="3"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>Centro de Oncologia do Hospital Srio-Libans, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of Oncology</title>
<idno type="ISSN">0923-7534</idno>
<idno type="eISSN">1569-8041</idno>
<imprint><publisher>Oxford University Press</publisher>
<date type="published" when="2009">2009</date>
<biblScope unit="volume">20</biblScope>
<biblScope unit="supplement">suppl_6</biblScope>
<biblScope unit="page" from="14">vi14</biblScope>
<biblScope unit="page" to="21">vi21</biblScope>
</imprint>
<idno type="ISSN">0923-7534</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0923-7534</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">The American Joint Committee on Cancer (AJCC) staging of cutaneous melanoma is a continuously evolving system. The identification of increasingly more accurate prognostic factors has led to major changes in melanoma staging over the years, and the current system described in this review will likely be modified in the near future. Likewise, application of new imaging techniques has also changed the staging work-up of patients with cutaneous melanoma. Chest and abdominal computed tomography (CT) scanning is most commonly used for evaluation of potential metastatic sites in the lungs, lymph nodes and liver, and is indicated in patients with new symptoms, anaemia, elevated lactate dehydrogenase or a chest X-ray abnormality. CT scans should be restricted to patients with high-risk melanoma (stage IIC, IIIB, IIIC and stage IIIA with a macroscopic sentinel lymph node). Magnetic resonance imaging (MRI) of the brain is a mandatory test in patients with stage IV, optional in stage III and not used in patients with stage I and II disease. Positron emission tomography (PET)/CT is more accurate than CT or MRI alone in the diagnosis of metastases and should complement conventional CT/MRI imaging in the staging work-up of patients who have solitary or oligometastatic disease where surgical resection is most relevant.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006450 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 006450 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:589851F42F3B662B4BF40B6CE86D13FE01352A8D |texte= Staging of cutaneous melanoma }}
This area was generated with Dilib version V0.6.31. |